Ultrasmall Water-Soluble and Biocompatible Magnetic Iron Oxide Nanoparticles as Positive and Negative Dual Contrast Agents
about
Nanoparticle-based systems for T(1)-weighted magnetic resonance imaging contrast agentsInorganic nanoparticle-based T1 and T1/T2 magnetic resonance contrast probes.One-step synthesis of water-dispersible ultra-small Fe3O4 nanoparticles as contrast agents for T1 and T2 magnetic resonance imaging.One-step, room-temperature synthesis of glutathione-capped iron-oxide nanoparticles and their application in in vivo T1-weighted magnetic resonance imaging.Facile non-hydrothermal synthesis of oligosaccharides coated sub-5 nm magnetic iron oxide nanoparticles with dual MRI contrast enhancement effect.An aqueous method for the controlled manganese (Mn(2+)) substitution in superparamagnetic iron oxide nanoparticles for contrast enhancement in MRI.Designed Synthesis of Nanostructured Magnetic Hydroxyapatite Based Drug Nanocarrier for Anti-Cancer Drug Delivery toward the Treatment of Human Epidermoid Carcinoma.Magnetic Nanoparticles: Material Engineering and Emerging Applications in Lithography and Biomedicine.Magnetically engineered semiconductor quantum dots as multimodal imaging probes.Highly monodisperse low-magnetization magnetite nanocubes as simultaneous T(1)-T(2) MRI contrast agents.Paramagnetic inorganic nanoparticles as T1 MRI contrast agents.T1-Enhanced MRI-visible nanoclusters for imaging-guided drug delivery.In vivo aggregation-induced transition between T1 and T2 relaxations of magnetic ultra-small iron oxide nanoparticles in tumor microenvironment.Using fluorescently-labeled magnetic nanocomposites as a dual contrast agent for optical and magnetic resonance imaging.Ultrasmall manganese ferrite nanoparticles as positive contrast agent for magnetic resonance imagingUltra-small fluorescent inorganic nanoparticles for bioimagingMicrowave-assisted synthesis of highly crystalline, multifunctional iron oxide nanocomposites for imaging applicationsDesign and Utility of Metal/Metal Oxide Nanoparticles Mediated by Thioether End-Functionalized Polymeric LigandsHighly water-soluble magnetic iron oxide (Fe3O4) nanoparticles for drug delivery: enhanced in vitro therapeutic efficacy of doxorubicin and MION conjugates
P2860
Q26824262-A6693A0B-1397-4BD0-A864-D905A4C9D544Q30564493-871150B1-3665-4C5A-8C30-8B2DA41B2363Q30746227-3905FE65-781E-47AE-923B-36C2E0BBB193Q30837537-75E59C70-8199-4406-A0AB-6AD284002C34Q30847182-EC8BB43E-ACDA-4D99-8375-0CFED0069E79Q30884375-FFDC08F6-4B42-4FCC-935E-88583440ECEAQ33837904-98F5CE49-47CD-4CE0-9C91-17B8B86B2CF4Q36283461-5DAC504B-0875-4C04-A3C9-D838D7B63649Q38245271-A3774AC0-496D-4E38-9FC7-AFF3CC4D829EQ38870993-724B6160-8777-4262-B8DD-4103FA177968Q45848579-3A3C4EAF-71A5-49B3-B1BA-5029761A274BQ47821106-F02AEBF3-655F-4B6D-B17E-FA4212CA8AABQ48253435-4B4696DB-4AAA-4D1C-AB12-E72F18C36C88Q50655598-87160B21-BD29-4DE1-B7B5-EF185C076505Q57183698-BD2692AF-A4F5-4D66-9D51-D2C1CF54AE87Q57376756-65960AF5-2A7B-499B-A6CA-1466C2DB5760Q58147406-9C30210C-2240-49E0-844F-B32416C56343Q59312958-729CC163-6A91-4C03-96E4-6EA77FE47A77Q59312976-05BF751B-3B44-4BCF-AD9C-9B22D31B2880
P2860
Ultrasmall Water-Soluble and Biocompatible Magnetic Iron Oxide Nanoparticles as Positive and Negative Dual Contrast Agents
description
im März 2012 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2012
@uk
name
Ultrasmall Water-Soluble and B ...... Negative Dual Contrast Agents
@en
Ultrasmall Water-Soluble and B ...... Negative Dual Contrast Agents
@nl
type
label
Ultrasmall Water-Soluble and B ...... Negative Dual Contrast Agents
@en
Ultrasmall Water-Soluble and B ...... Negative Dual Contrast Agents
@nl
prefLabel
Ultrasmall Water-Soluble and B ...... Negative Dual Contrast Agents
@en
Ultrasmall Water-Soluble and B ...... Negative Dual Contrast Agents
@nl
P2093
P2860
P356
P1476
Ultrasmall Water-Soluble and B ...... Negative Dual Contrast Agents
@en
P2093
Gao Qing Max Lu
Hong Li Zhao
Min Bo Lan
Pei Wei Yi
Sean C. Smith
Zhong Hua Zhu
P2860
P304
P356
10.1002/ADFM.201103123
P407
P50
P577
2012-03-15T00:00:00Z